Abstract

This comprehensive analysis examines pharmaceutical policies, pricing strategies, and reimbursement systems across different healthcare models. The study evaluates access to medicines, affordability challenges, and policy interventions to improve medication availability.

---

References

1. Rowe RC, Sheskey PJ, Quinn ME, editors. Handbook of Pharmaceutical Excipients. 8th ed. London: Pharmaceutical Press; 2017.

2. Katdare A, Chaubal MV. Excipient functionality and innovation in pharmaceutical formulation. J Pharm Sci. 2006;95(4):821–832.

3. Thoorens G, Krier F, Leclercq B, Carlin B, Evrard B. Microcrystalline cellulose, a direct compression binder in pharmaceutical formulations—A review. Int J Pharm. 2014;473(1–2):64–72.

4. Williams RO, Watts AB, Miller DA. Formulating Poorly Water Soluble Drugs. 2nd ed. New York: Springer; 2016.

5. Goole J, Amighi K. New trends in pharmaceutical excipients for oral drug delivery. Int J Pharm. 2014;466(1–2):45–52.

6. Pifferi G, Restani P. The safety of pharmaceutical excipients. Farmaco. 2003;58(8):541–550.

7. Van der Merwe SM, Grobler AF, Steenekamp JH. Functional excipients in solid dosage forms: Applications and future perspectives. Drug Dev Ind Pharm. 2020;46(5):689–701.